IFNA1 and neoplasm: Our results suggest that patients in the high-risk group have a reduced ability to kill tumor cells because of the antitumor effects of NK cells and IFN response, and may be caused by suppressed antiviral immunity, but the specific mechanisms underlying these relationships remain unclear.